Collegium Pharmaceutical, Inc.
COLL
$32.04
-$1.17-3.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.69% | -52.95% | 43.68% | 882.63% | 995.02% |
| Total Depreciation and Amortization | 47.32% | 29.97% | 13.34% | -2.63% | -6.20% |
| Total Amortization of Deferred Charges | -28.34% | -31.07% | -30.33% | -27.61% | -20.50% |
| Total Other Non-Cash Items | -28.90% | 17.37% | -66.81% | -51.56% | -48.51% |
| Change in Net Operating Assets | -6,107.14% | -258.79% | -352.99% | -255.95% | -103.36% |
| Cash from Operations | -26.46% | -35.78% | -25.39% | -27.66% | 17.00% |
| Capital Expenditure | -57.17% | -120.63% | -258.35% | -0.73% | 16.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.52% | 88.75% | 73.61% | 28.86% | -31.74% |
| Cash from Investing | -388.48% | -214.67% | -306.37% | -545.36% | -30.29% |
| Total Debt Issued | 5,075.16% | 5,459.36% | 34.58% | 35.81% | -97.33% |
| Total Debt Repaid | 1.61% | -50.53% | -1.50% | -19.64% | 16.54% |
| Issuance of Common Stock | -77.62% | -11.15% | 21.67% | 11.13% | 13.75% |
| Repurchase of Common Stock | 52.33% | 13.09% | 5.00% | -20.22% | -482.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -208.60% | -97.13% | -88.30% | -- | -- |
| Cash from Financing | 110.30% | 87.93% | 56.77% | 11.23% | -874.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.80% | -165.67% | -324.88% | -258.31% | -169.49% |